Stock Analysis
Topdanmark (CPH:TOP) First Quarter 2024 Results
Key Financial Results
- Revenue: kr.3.04b (up 16% from 1Q 2023).
- Net income: kr.377.0m (up 1.1% from 1Q 2023).
- Profit margin: 12% (down from 14% in 1Q 2023). The decrease in margin was driven by higher expenses.
- EPS: kr.4.24 (up from kr.4.21 in 1Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Topdanmark Revenues and Earnings Beat Expectations
Revenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) also surpassed analyst estimates by 45%.
Looking ahead, revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 5.8% growth forecast for the Insurance industry in Europe.
Performance of the market in Denmark.
The company's shares are up 6.7% from a week ago.
Risk Analysis
We should say that we've discovered 1 warning sign for Topdanmark that you should be aware of before investing here.
Valuation is complex, but we're helping make it simple.
Find out whether Topdanmark is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About CPSE:TOP
Topdanmark
Topdanmark A/S, together with its subsidiaries, offers life and non-life insurance products and services in Denmark.
Excellent balance sheet and slightly overvalued.